American Journal of Kidney Diseases
Volume 54, Issue 3 , Pages 406-409 , September 2009

Plasma “Factors” in Recurrent Nephrotic Syndrome After Kidney Transplantation: Causes or Consequences of Glomerular Injury?

  • Virginia J. Savin, MD

      Affiliations

    • Corresponding Author InformationAddress correspondence to Virginia J. Savin, MD, Medical College of Wisconsin, 9200 W Wisconsin Ave, Milwaukee, WI 53226
    • ,
  • Mukut Sharma, PhD

References 

  1. Hoyer JR, Vernier RL, Najarian JS, Raij L, Simmons RL, Michael AF. Recurrence of idiopathic nephrotic syndrome after renal transplantation. 1972 J Am Soc Nephrol. 2001;12:1994–2002
  2. Fine RN. Recurrence of nephrotic syndrome/focal segmental glomerulosclerosis following renal transplantation in children. Pediatr Nephrol. 2007;22:496–502
  3. Artero ML, Sharma R, Savin VJ, Vincenti F. Plasmapheresis reduces proteinuria and serum capacity to injure glomeruli in patients with recurrent focal glomerulosclerosis. Am J Kidney Dis. 1994;23:574–581
  4. Dantal J, Bigot E, Bogers W, et al. Effect of plasma protein adsorption on protein excretion in kidney-transplant recipients with recurrent nephrotic syndrome. N Engl J Med. 1994;330:7–14
  5. Dantal J, Godfrin Y, Koll R, et al. Antihuman immunoglobulin affinity immunoadsorption strongly decreases proteinuria in patients with relapsing nephrotic syndrome. J Am Soc Nephrol. 1998;9:1709–1715
  6. Zimmerman SW. Increased urinary protein excretion in the rat produced by serum from a patient with recurrent focal glomerular sclerosis after renal transplantation. Clin Nephrol. 1984;22:32–38
  7. Sharma M, Sharma R, Reddy SR, McCarthy ET, Savin VJ. Proteinuria after injection of human focal segmental glomerulosclerosis factor. Transplantation. 2002;73:366–372
  8. Savin VJ, Sharma R, Sharma M, et al. Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis. N Engl J Med. 1996;334:878–883
  9. Godfrin Y, Dantal J, Perretto S, et al. Study of the in vitro effect on glomerular albumin permselectivity of serum before and after renal transplantation in focal segmental glomerulosclerosis. Transplantation. 1997;64:1711–1715
  10. Carraro M, Caridi G, Bruschi M, et al. Serum glomerular permeability activity in patients with podocin mutations (NPHS2) and steroid-resistant nephrotic syndrome. J Am Soc Nephrol 13. 2002;1946–1952
  11. Pegoraro AA, Singh AK, Arruda JA, Dunea G, Bakir AA. A simple method to detect an albumin permeability factor in the idiopathic nephrotic syndrome. Kidney Int. 2000;58:1342–1345
  12. Trachtman H, Futterweit S, Singhal PC, et al. Circulating factor in patients with recurrent focal segmental glomerulosclerosis post renal transplantation inhibits expression of inducible nitric oxide synthase and nitric oxide production by cultured rat mesangial cells. J Investig Med. 1999;47:114–120
  13. Kemper MJ, Wolf G, Müller-Wiefel DE. Transmission of glomerular permeability factor from a mother to her child. N Engl J Med. 2001;344:386–387
  14. Sellier-Leclerc AL, Duval A, Riveron S, et al. Humanized mouse model of idiopathic nephrotic syndrome suggests a pathogenic role for immature cells. J Am Soc Nephrol. 2007;18:2732–2739(abstr)
  15. Sharma M, Sharma R, McCarthy ET, Savin VJ. The focal segmental glomerulosclerosis permeability factor: Biochemical characteristics and biological effects. Exp Biol Med (Maywood). 2004;229:85–98
  16. Savin VJ, McCarthy ET, Sharma R, Charba D, Sharma M. Galactose binds to focal segmental glomerulosclerosis permeability factor and inhibits its activity. Transl Res. 2008;151:288–292
  17. Musante L, Candiano G, Bruschi M, et al. Characterization of plasma factors that alter the permeability to albumin within isolated glomeruli. Proteomics. 2002;2:197–205
  18. Bruschi M, Catarsi P, Candiano G, et al. Apolipoprotein E in idiopathic nephrotic syndrome and focal segmental glomerulosclerosis. Kidney Int. 2003;63:686–695
  19. Musante L, Candiano G, Petretto A, et al. Active focal segmental glomerulosclerosis is associated with massive oxidation of plasma albumin. J Am Soc Nephrol. 2007;18:799–810
  20. Candiano G, Musante L, Petretto A, et al. Proteomics of plasma and urine in primary nephrotic syndrome in children. Contrib Nephrol. 2008;160:17–28
  21. Bruneau S, Le Berre L, Hervé C, et al. Potential role of soluble ST2 protein in idiopathic nephrotic syndrome recurrence following kidney transplantation. Am J Kidney Dis. 2009;54:523–532
  22. Savin VJ, Sharma M, McCarthy ET, et al. Cardiotrophin like cytokine-1: Candidate for the focal glomerular sclerosis permeability factor (F-FC-260). J Am Soc Nephrol. 2008;19:59A;(abstr)
  23. Wei C, Saleem M, Goes N, et al. Soluble urokinase receptor (suPAR) is a circulating glomerular disease recurrence factor (SA-FC-454). J Am Soc Nephrol. 2008;19:103A;(abstr)
  24. Kestilä M, Lenkkeri U, Männikkö M, et al. Positionally cloned gene for a novel glomerular protein—Nephrin—is mutated in congenital nephrotic syndrome. Mol Cell. 1998;1:575–582
  25. Daskalakis N, Winn MP. Focal and segmental glomerulosclerosis. Cell Mol Life Sci. 2006;63:2506–2525
  26. Tsukaguchi H, Sudhakar A, Le TC, et al. NPHS2 mutations in late-onset focal segmental glomerulosclerosis: R229Q is a common disease-associated allele. J Clin Invest. 2002;110:1659–1666
  27. Ghiggeri GM, Aucella F, Caridi G, et al. Posttransplant recurrence of proteinuria in a case of focal segmental glomerulosclerosis associated with WT1 mutation. Am J Transplant. 2006;6:2208–2211
  28. Srivastava T, Garola RE, Kestila M, et al. Recurrence of proteinuria following renal transplantation in congenital nephrotic syndrome of the Finnish type. Pediatr Nephrol. 2006;21:711–718
  29. Becker-Cohen R, Bruschi M, Rinat C, et al. Recurrent nephrotic syndrome in homozygous truncating NPHS2 mutation is not due to anti-podocin antibodies. Am J Transplant. 2007;7:256–260
  30. Jeansson M, Björck K, Tenstad O, Haraldsson B. Adriamycin alters glomerular endothelium to induce proteinuria. J Am Soc Nephrol. 2009;20:114–122
  31. Appel GB, Fine PL, Fenves AZ, et al. Collapsing focal segmental glomerulosclerosis following treatment with high-dose pamidronate. J Am Soc Nephrol. 2001;12:1164–1172
  32. Shah SN, He CJ, Klotman P. Update on HIV-associated nephropathy. Curr Opin Nephrol Hypertens. 2006;15:450–455
  33. Moudgil A, Nast CC, Bagga A, et al. Association of parvovirus B19 infection with idiopathic collapsing glomerulopathy. Kidney Int. 2001;59:2126–2133
  34. Savin VJ, Sharma R, Lovell HB, Welling DJ. Measurement of albumin reflection coefficient in isolated rat glomeruli. J Am Soc Nephrol. 1992;3:1260–1269
  35. Ghiggeri GM, Artero M, Carraro M, et al. Glomerular albumin permeability as an in vitro model for characterizing the mechanism of focal glomerulosclerosis and predicting post-transplant recurrence. Pediatr Transplant. 2004;8:339–343
  36. Varghese SA, Powell TB, Budisavljevic MN, et al. Urine biomarkers predict the cause of glomerular disease. J Am Soc Nephrol. 2007;18:913–922
  37. Garin EH, Diaz LN, Mu W, et al. Urinary CD80 excretion increases in idiopathic minimal-change disease. J Am Soc Nephrol. 2009;20:260–266
  38. Le Berre L, Hervé C, Buzelin F, Usal C, Soulillou JP, Dantal J. Renal macrophage activation and Th2 polarization precedes the development of nephrotic syndrome in Buffalo/Mna rats. Kidney Int. 2005;68:2079–2090
  39. Vaden SL, Hammerberg B, Davenport DJ, et al. Food hypersensitivity reactions in soft coated Wheaten terriers with protein-losing enteropathy or protein-losing nephropathy or both: Gastroscopic food sensitivity testing, dietary provocation, and fecal immunoglobulin E. J Vet Intern Med. 2000;14:60–67

PII: S0272-6386(09)00873-7

doi: 10.1053/j.ajkd.2009.06.010

American Journal of Kidney Diseases
Volume 54, Issue 3 , Pages 406-409 , September 2009

Article Tools